South Africa’s pharmaceutical policy must protect patients through affordable medicines. Still, it cannot pursue the lowest possible price at the cost of the local industry that keeps those medicines flowing, an industry expert argues. Writing from years in the sector and doctoral research on generic pricing, the author poses a harder question. What happens when the drive for cheap medicines…